Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rosan Kreeftmeijer-Vegter"'
Autor:
Julia White, Petr Kocis, Florence Bietrix, Matthew D. Hall, Rosan Kreeftmeijer-Vegter, Nobuyoshi Chiba, Justin Bryans, Christopher P. Austin, Anton E. Ussi, Makoto Suematsu, Stuart Newman, Ryutaro Hirasawa, C. Taylor Gilliland, Barry Gee, Marian Hajduch
Publikováno v:
ACS Pharmacol Transl Sci
Translational science is defined as the field of investigation focused on understanding the scientific and operational principles underlying each step of the translational process. Further development of the field is advanced by describing the key de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4684ca79dc101cd5b254ce6e6ef1e5af
https://europepmc.org/articles/PMC7088880/
https://europepmc.org/articles/PMC7088880/
Autor:
Jeff Kipling, Christa Janko, Armel Stockis, Anita Aperia, Rosan Kreeftmeijer-Vegter, Lena Scott, Michael Hardman, Rebecca Ludwig, Jorgen Dirach
Publikováno v:
Journal of Medicines Development Sciences. 4:1
“No research without trained researchers” has become the mantra of the EU-funded Innovative Medicines Initiative (IMI) education and training projects. However, it is often hard to determine the type of training required at different stages of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c968c4331b9ebdd6bc67c1a4c629450
https://doi.org/10.18063/jmds.v2i2.163
https://doi.org/10.18063/jmds.v2i2.163
Autor:
A. de Boer, P. J. de Vries, Thomas P. C. Dorlo, Annemarie Rosan Kreeftmeijer-Vegter, M. P. Gruppen
Publikováno v:
British Journal of Clinical Pharmacology. 80:242-252
Aim The aim was to investigate the population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome. Methods Non-linear mixed effects modelling was performed on samples collected during a randomized controlled trial. Sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32b6c7d8f4c4971aa1ea589ff36eb14b
https://doi.org/10.1111/bcp.12607
https://doi.org/10.1111/bcp.12607
Autor:
Mariska de Meijer, Kim A M Wegman, Cees K. W. van Veldhuizen, Annemarie Rosan Kreeftmeijer-Vegter
Publikováno v:
Expert opinion on drug delivery. 10(3)
To develop an oral solid dosage form of levamisole suitable for the paediatric population in terms of dose accuracy, palatability, stability and ease of administration.Small undividable tablets (Ø5 - 8 mm) in four different strengths were manufactur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f800f9a191411f6ea4774d7ab23a22
https://pubmed.ncbi.nlm.nih.gov/23289762
https://pubmed.ncbi.nlm.nih.gov/23289762
Autor:
Mariana de Mendonça Melo, Perry J.J. van Genderen, Rob Koelewijn, Jaap J. van Hellemond, Peter J. de Vries, Annemarie Rosan Kreeftmeijer-Vegter
Publikováno v:
Malaria Journal, 12. BioMed Central Ltd.
Malaria Journal
Malaria journal, 12(1). BioMed Central
Malaria Journal
Malaria journal, 12(1). BioMed Central
Background Exchange transfusion (ET) has remained a controversial adjunct therapy for the treatment of severe malaria. In order to assess the relative contribution of ET to parasite clearance in severe malaria, all patients receiving ET as an adjunct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeba75388fdd2892ce9f72a2f2335b50
https://doi.org/10.1186/1475-2875-12-115
https://doi.org/10.1186/1475-2875-12-115
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 156(17)
Orphan drugs are drugs used in the treatment of life-threatening or chronic diseases that affect fewer than 1 out of 2000 persons in the European Union. Since the implementation of the European Regulation on Orphan Medicinal Products in 2000, 61 orph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::083825c2b09ea63c9062cfa2c3dacda7
https://pubmed.ncbi.nlm.nih.gov/22531041
https://pubmed.ncbi.nlm.nih.gov/22531041
Autor:
Perry J.J. van Genderen, Jan Clerinx, Annemarie Rosan Kreeftmeijer-Vegter, Leo G. Visser, Cees K. W. van Veldhuizen, Peter J. de Vries, Wouter F W Bierman
Publikováno v:
Malaria journal, 11(1). BioMed Central
Malaria Journal
Malaria journal, 11:102. BioMed Central Ltd.
Malaria Journal, 11
Malaria Journal, Vol 11, Iss 1, p 102 (2012)
Malaria Journal
Malaria journal, 11:102. BioMed Central Ltd.
Malaria Journal, 11
Malaria Journal, Vol 11, Iss 1, p 102 (2012)
Background Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, however, no GMP-manufactured product is available and treatment data in European travellers are scarce. Fortunately, artesunate became available in the N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08a39e3a766ebc91639e34ff42dd5179
https://hdl.handle.net/11370/645370ed-f0e5-4e65-a694-d4880256b059
https://hdl.handle.net/11370/645370ed-f0e5-4e65-a694-d4880256b059
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases, 8(1). BioMed Central
Orphanet journal of rare diseases, 8(1). BioMed Central
Background Intravenous (IV) artesunate is the treatment of choice for severe malaria. In Europe, this treatment is only available in a few countries via named patient programmes (NPPs). As a case study, the legal and organisational aspects and pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9bda402ff8d9f3981c2546713daf80d
https://doi.org/10.1186/1750-1172-8-150
https://doi.org/10.1186/1750-1172-8-150